![Stephen Hauser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Stephen Hauser
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Neurona Therapeutics, Inc.
![]() Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA.
11
| Holding Company | Biotechnology | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Stephen Hauser via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
The Column Group LLC
![]() The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree | |
PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
KAI Pharmaceuticals, Inc.
![]() KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kallyope, Inc.
![]() Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Stanford University | College/University | Undergraduate Degree | |
APTARGROUP, INC. | Containers/Packaging | Director/Board Member | |
Surrozen Operating, Inc.
![]() Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer | |
UCB Ventures (Private Equity)
![]() UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom. | Investment Managers | Director/Board Member | |
SpliceBio SL
![]() SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Rinri Therapeutics Ltd.
![]() Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
StrideBio, Inc.
![]() StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Exevir Bio BV
![]() Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
UCB Ventures London | Investment Managers | Private Equity Investor | |
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Chairman | |
Synthekine, Inc.
![]() Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
Hc Bioscience, Inc.
![]() Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Eikon Therapeutics, Inc.
![]() Eikon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eikon Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Hayward, CA. | Miscellaneous Commercial Services | Founder | |
GERON CORPORATION | Biotechnology | Corporate Officer/Principal | |
Baxalta US, Inc.
![]() Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Biotechnology | Corporate Officer/Principal | |
NKARTA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The International Society for Stem Cell Research | Director/Board Member | ||
Proteus RM LLC (Venture Capital)
![]() Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Investment Managers | Consultant / Advisor | |
Innovative Genomics Institute | Director/Board Member | ||
National Academy of Sciences
![]() National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Nura Bio, Inc.
![]() Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder | |
Howard Hughes Medical Institute, Inc.
![]() Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | President | |
Howard Hughes Medical Institute, Inc. (Investment Management)
![]() Howard Hughes Medical Institute, Inc. (Investment Management) Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. (Investment Management) (HHMI-IM) is the investment management division of Howard Hughes Medical Institute, Inc. (HHMI), a non-profit medical research organization headquartered in Chevy Chase, Maryland. Founded in 1953, HHMI-IM manages the investment of HHMI which supports basic biomedical scientists and science educators with the potential for transformative impact. | Investment Trusts/Mutual Funds | President | |
Kimia Therapeutics, Inc.
![]() Kimia Therapeutics, Inc. BiotechnologyHealth Technology Kimia Therapeutics, Inc. is a drug discovery company that utilizes high throughput precision chemistry, genome editing, and machine learning to identify druggable sites for human disease intervention. The private company is based in Berkeley, CA. The company is building a next-generation therapeutics discovery platform called Atlas, which combines active learning with automated synthesis and screening. Atlas is powered by a high-throughput, nano-liter scale chemistry platform that provides Kimia with instant access to billions of drug-like compounds. The CEO of the company is Stig K. Hansen. | Biotechnology | Founder | |
InduPro, Inc.
![]() InduPro, Inc. BiotechnologyHealth Technology InduPro, Inc. engages in integrating inherent protein proximity at the cell surface and translates biological insights into transformative therapeutics. The company is based in San Francisco, CA. The company was founded by K. Christopher Garcia. | Biotechnology | Director/Board Member | |
Cajal Neuroscience, Inc.
![]() Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | Biotechnology | Director/Board Member | |
Plexium, Inc.
![]() Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
SURROZEN, INC. | Biotechnology | Chairman | |
Global Genes
![]() Global Genes Miscellaneous Commercial ServicesCommercial Services Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin. | Miscellaneous Commercial Services | Director/Board Member | |
ARVINAS, INC. | Biotechnology | Director/Board Member | |
Network For Excellence In Neuroscience Clinical Trials | Corporate Officer/Principal | ||
ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Hofstra University | College/University | Director/Board Member | |
Seragon Pharmaceuticals, Inc.
![]() Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
HONEYWELL INTERNATIONAL INC. | Aerospace & Defense | Corporate Officer/Principal | |
Cold Spring Harbor Laboratory, Inc.
![]() Cold Spring Harbor Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Cold Spring Harbor Laboratory, Inc. provides research services. It operates educational institutions. The firm offers research in cancer, neurobiology, plant genetics, and bioinformatics. It also offers laboratory workshops to science teachers, students, and other groups across the nation. The company was founded in 1890 and is headquartered in Cold Spring Harbor, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Aragon Pharmaceuticals, Inc.
![]() Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
USBX Advisory Services LLC
![]() USBX Advisory Services LLC Investment ManagersFinance USBX Advisory Services LLC provides investment advisory services. It is an investment banking firm that provides mergers and acquisitions advisory services including sales and divestiture, management buyouts, and recapitalization's. The company also offers private placement's in equity, subordinate debt, and growth capital. USBX Advisory Services was founded by John E. Mack III in April 2000 and is located in Santa Monica, CA. | Investment Managers | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 45 |
Verenigd Koninkrijk | 4 |
België | 3 |
Spanje | 2 |
Sectoraal
Health Technology | 25 |
Finance | 7 |
Commercial Services | 7 |
Consumer Services | 5 |
Miscellaneous | 3 |
Operationeel
Director/Board Member | 56 |
Corporate Officer/Principal | 12 |
Founder | 11 |
Chairman | 11 |
Chief Executive Officer | 8 |
Sterkste connecties
Insiders | |
---|---|
Leo Guthart | 25 |
Bradley Margus | 19 |
Timothy Kutzkey | 18 |
Robert Tjian | 10 |
Erica Whittaker | 8 |
Ralph Brandenberger | 5 |
Arnold Kriegstein | 3 |
Cory Nicholas | 1 |
Arturo Buylla | 1 |
John Rubenstein | 1 |
Alessandro Bulfone | 1 |
- Beurs
- Insiders
- Stephen Hauser
- Bedrijfsconnecties